首页> 外文期刊>Journal of endovascular therapy: an official journal of the International Society of Endovascular Specialists >Adjunctive procedures for the treatment of proximal type I endoleak: the role of peri-aortic ligatures and Palmaz stenting.
【24h】

Adjunctive procedures for the treatment of proximal type I endoleak: the role of peri-aortic ligatures and Palmaz stenting.

机译:近端I型内漏的辅助治疗:主动脉周围结扎和Palmaz支架置入的作用。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: To investigate the feasibility, efficacy, and long-term effects of peri-aortic ligatures and Palmaz stenting used to treat proximal type I endoleak after endovascular repair (EVR) of abdominal aortic aneurysm (AAA). METHODS: An 8-year single-center experience with proximal type I endoleak was reviewed; the records of the 55 identified cases were examined to ascertain the methods of treatment used. Among these, all 22 patients who were treated with peri-aortic ligatures and Palmaz stenting were segregated for analysis. RESULTS: The 22 patients (14 men; mean age 74.6 years, range 66-85) with proximal type I endoleak (18 early, 4 late) selected for analysis underwent 23 secondary procedures: 15 involving peri-aortic ligatures and 8 Palmaz stent implantations. Of the 18 early endoleaks, 11 were treated intraoperatively and 7 were observed. Ten (45%) patients died within 30 days of endoleak treatment: 8 had early endoleaks. Five of the 10 deaths occurred in patients successfully treated with peri-aortic ligatures (3/10) or Palmaz stenting (2/7). The 12 (54%) surviving patients suffered no aneurysm-related deaths or secondary endoleaks over a median follow-up of 20 months (range 4-75). CONCLUSIONS: Endoleak is an important mode of failure after endovascular repair. Peri-aortic ligatures and Palmaz stenting are feasible techniques for the treatment of proximal endoleak; however, the perioperative mortality of peri-aortic ligatures was higher when compared with other less invasive techniques. In contrast to other therapeutic options, these methods are more effective in the short and medium term.
机译:目的:探讨在腹主动脉瘤(AAA)血管内修复(EVR)后主动脉周围结扎和Palmaz支架置入治疗I型近端内漏的可行性,疗效和长期效果。方法:回顾了8年的I型近端内漏的单中心经验。检查了55例确诊病例的记录,以确定所使用的治疗方法。在这些患者中,将所有22位接受主动脉周围结扎和Palmaz支架治疗的患者分开进行分析。结果:22例患者(14例;平均年龄74.6岁,范围66-85)选择进行近端I型内漏(18例早期,4例晚期)进行了23例次要手术:15例涉及主动脉周围结扎和8例Palmaz支架植入术。在18例早期内漏中,有11例在术中接受了治疗,观察到7例。内渗治疗30天内有10名(45%)患者死亡:8例发生内渗早期。 10例死亡中有5例发生在成功接受主动脉周围结扎(3/10)或Palmaz支架置入术(2/7)的患者中。在中位随访20个月(范围4-75)中,有12名(54%)存活的患者未发生与动脉瘤相关的死亡或继发性内漏。结论:内漏是血管内修复后失败的重要方式。主动脉周围的结扎术和Palmaz支架置入术是治疗近端内漏的可行技术。但是,与其他微创技术相比,主动脉周围结扎的围手术期死亡率更高。与其他治疗选择相反,这些方法在短期和中期都更有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号